SCM
TMO icon

Spreng Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Spreng Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Hold
833
– – 0.15% 55
2026
Q1 		$409K Sell
833
-42
-5% -$22.8K 0.19% 50
2025
Q4 		$507K Hold
875
– – 0.2% 51
2025
Q3 		$424K Sell
875
-17
-2% -$7.91K 0.17% 58
2025
Q2 		$362K Sell
892
-15
-2% -$6.27K 0.15% 63
2025
Q1 		$451K Hold
907
– – 0.2% 55
2024
Q4 		$472K Hold
907
– – 0.21% 57
2024
Q3 		$561K Sell
907
-356
-28% -$211K 0.26% 52
2024
Q2 		$698K Buy
1,263
+15
+1% +$8.59K 0.36% 47
2024
Q1 		$725K Sell
1,248
-6
-0.5% -$3.37K 0.39% 47
2023
Q4 		$666K Sell
1,254
-19
-1% -$9.2K 0.42% 47
2023
Q3 		$644K Buy
1,273
+25
+2% +$13.3K 0.47% 45
2023
Q2 		$651K Buy
1,248
+50
+4% +$27K 0.51% 43
2023
Q1 		$690K Buy
1,198
+35
+3% +$19.7K 0.6% 43
2022
Q4 		$640K Sell
1,163
-275
-19% -$146K 0.55% 43
2022
Q3 		$729K Sell
1,438
-30
-2% -$16.8K 0.65% 41
2022
Q2 		$813K Sell
1,468
-165
-10% -$90.8K 0.61% 42
2022
Q1 		$964K Sell
1,633
-84
-5% -$48.3K 0.59% 41
2021
Q4 		$1.15M Hold
1,717
– – 0.66% 38
2021
Q3 		$983K Hold
1,717
– – 0.63% 39
2021
Q2 		$866K Buy
1,717
+97
+6% +$45.8K 0.56% 44
2021
Q1 		$739K Buy
1,620
+35
+2% +$16.7K 0.51% 45
2020
Q4 		$738K Sell
1,585
-302
-16% -$142K 0.58% 39
2020
Q3 		$833K Sell
1,887
-18
-0.9% -$7.44K 0.79% 35
2020
Q2 		$690K Sell
1,905
-125
-6% -$41.9K 0.7% 39
2020
Q1 		$576K Sell
2,030
-160
-7% -$50.5K 0.66% 38
2019
Q4 		$711K Buy
+2,190
New +$664K 0.66% 40

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Spreng Capital Management's TMO Position: Q2 2026 in Review

Spreng Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 833 shares worth $418K. The position accounts for 0.15% of the portfolio, ranked #55.

Spreng Capital Management first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.15M in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Spreng Capital Management held 833 shares of Thermo Fisher Scientific worth $418K as of Q2 2026.
  • Spreng Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up 0.15% of Spreng Capital Management's portfolio in Q2 2026, its #55 holding.
  • Spreng Capital Management first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Spreng Capital Management's Thermo Fisher Scientific position peaked at $1.15M in Q4 2021.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Spreng Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.